| | Class 2 Device Recall Alinity |  |
| Date Initiated by Firm | February 11, 2022 |
| Create Date | March 02, 2022 |
| Recall Status1 |
Terminated 3 on April 14, 2023 |
| Recall Number | Z-0710-2022 |
| Recall Event ID |
89603 |
| Product Classification |
real time Nucleic acid amplification system - Product Code OOI
|
| Product | Alinity m Integrated Reaction Units (IRU) |
| Code Information |
List Number 09N26-010, Lot Numbers/UDI:
1) 766233 / (01)20884999047864(10)766233(11)210614(240)09N26-010
2) 770433 / (01)20884999047864(10)770433(11)210621(240)09N26-010
3) 771200 / (01)20884999047864(10)771200(11)210712(240)09N26-010
4) 771201 / (01)20884999047864(10)771201(11)210719(240)09N26-010
5) 773642 / (01)20884999047864(10)773642(11)210723(240)09N26-010 |
Recalling Firm/ Manufacturer |
Abbott Molecular, Inc. 1300 E Touhy Ave Des Plaines IL 60018-3315
|
| For Additional Information Contact | Ray Bastian 224-361-7000 |
Manufacturer Reason for Recall | There is potential for the Reaction Vessels (RVs) detaching from the RV cap during transport by the pipettor robot. |
FDA Determined Cause 2 | Under Investigation by firm |
| Action | On February 11, 2022, Abbott Molecular issued a Product Recall letter to all
customers who received Integrated Reaction Unit (IRU) List Number 09N26-010 Lot
Numbers 766233, 770433, 771200, 771201, and 773642 used with the Alinity m System.
Consignees must complete and return the included customer reply form.
Customers are instructed to follow the Necessary Actions outlined in the Customer Letter:
Discontinue use of and discard all remaining inventory of IRU Lots 766233, 770433,
771200, 771201, and 773642. To coordinate replacement, contact your local Molecular
Diagnostics at Abbott representative.
If RVs are found inside the instrument with no cap and there are associated 1998 errors,
please contact an Abbott representative to inspect the instrument. Results generated between the onset of the associated 1998 errors and the identification of the RV with no cap inside the instrument should be considered presumptive. Retesting of samples that yielded positive results during this timeframe should be considered. |
| Quantity in Commerce | 3063 kits |
| Distribution | US Nationwide distribution in the states of AZ, CA, CO, CT, DC, FL, GA, IL, KY, LA, MA, MI, MO, NC, NJ, NY, OK, RI, SD, TX, WA, and WI. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|